Search | IOVS | ARVO Journals

Showing 1 – 20 of 22

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Artificial Intelligence February 2025

Deep Learning Approaches to Predict Geographic Atrophy Progression Using Three-Dimensional OCT Imaging

PDF

Kenta Yoshida; Neha Anegondi; Adam Pely; Miao Zhang; Frederic Debraine; Karthik Ramesh; Verena Steffen; Simon S. Gao; Catherine Cukras; Christina Rabe; Daniela Ferrara; Richard F. Spaide; SriniVas R. Sadda; Frank G. Holz; Qi Yang
TAGS: age-related macular degeneration, nonexudative, datasets, deep learning, diagnostic imaging, growth rate
Trans. Vis. Sci. Tech.. 2025; 14(2):11. https://doi.org/10.1167/tvst.14.2.11

Includes: Supplemental Content

Artificial Intelligence August 2024

Topographic Clinical Insights From Deep Learning–Based Geographic Atrophy Progression Prediction

PDF

Julia Cluceru; Neha Anegondi; Simon S. Gao; Aaron Y. Lee; Eleonora M. Lad; Usha Chakravarthy; Qi Yang; Verena Steffen; Michel Friesenhahn; Christina Rabe; Daniela Ferrara
TAGS: ablation, age-related macular degeneration, nonexudative, datasets, deep learning, masks, diagnostic imaging, growth rate, pixel, shape
Trans. Vis. Sci. Tech.. 2024; 13(8):6. https://doi.org/10.1167/tvst.13.8.6

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Artificial Intelligence Quantified Outer Retinal Disruption On Optical Coherence Tomography As Clinical Endpoints For Geographic Atrophy

Adam Pely; Simon S. Gao; Katie M Litts; Zhichao Wu; Theodore Leng; Verena Steffen; Hao Chen; Dolly Shuo-Teh Chang; Mohsen Hejrati; Miao Zhang

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2344.

Retina July 2023

Geographic Atrophy Segmentation Using Multimodal Deep Learning

PDF

Theodore Spaide; Jiaxiang Jiang; Jasmine Patil; Neha Anegondi; Verena Steffen; Michael G. Kawczynski; Elizabeth M. Newton; Christina Rabe; Simon S. Gao; Aaron Y. Lee; Frank G. Holz; SriniVas Sadda; Steffen Schmitz-Valckenberg; Daniela Ferrara
TAGS: atrophy, datasets, deep learning, screening, training, diagnostic imaging
Trans. Vis. Sci. Tech.. 2023; 12(7):10. https://doi.org/10.1167/tvst.12.7.10

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

HONU: A multicenter, prospective, observational study of the progression of intermediate age-related macular degeneration

Robyn H Guymer; Zhichao Wu; Simon Gao; Miao Zhang; Verena Steffen; Katie Litts; Michael C Chang; Justin Elsrott; Chen Chen; Jiameng Zhang; Liang Liu; Hao Chen

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2754.

ARVO Annual Meeting Abstract June 2023

Visual function loss in geographic atrophy: learnings from lampalizumab trial data

Verena Steffen; Neha Anegondi; Daniela Ferrara; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4329.

ARVO Annual Meeting Abstract June 2022

A hierarchical optical coherence tomography annotation workflow with crowds and medical experts

Miao Zhang; Simon S Gao; Verena Steffen; Zhichao Wu; Theodore Leng; Mahdi Abbaspour Tehrani; Seyyedeh Qazale Mirsharif; Nagamurali Movva; Mohsen Hejrati; Hao Chen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3013 – F0283.

ARVO Annual Meeting Abstract June 2022

Development and validation of prognostic models to increase power of clinical trials for geographic atrophy (GA)

Verena Steffen; Neha Anegondi; Qi Yang; Michel Friesenhahn; Daniela Ferrara; Simon S Gao; Christina Rabe

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1498.

ARVO Annual Meeting Abstract June 2022

Quantification of lesion progression of incomplete and complete retinal pigment epithelium and outer retinal atrophy in age-related macular degeneration

Steffen Schmitz-Valckenberg; Marlene Sassmannshausen; Martina Braun; Verena Steffen; Simon S Gao; Lee Honigberg; Daniela Ferrara; Maximilian Pfau; Frank G Holz

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2321.

ARVO Annual Meeting Abstract June 2022

Feature discovery using ablation studies for deep learning–based geographic atrophy (GA) progression prediction

Julia Cluceru; Neha Anegondi; Qi Yang; Verena Steffen; Christina Rabe; Michel Friesenhahn; Daniela Ferrara; Simon S Gao

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3859.

ARVO Annual Meeting Abstract June 2021

Clinical trial versus real-world outcomes with anti-VEGF therapy for branch and central retinal vein occlusion

Carl J Danzig; Steven Blotner; Verena Steffen; Zdenka Haskova

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3174.

ARVO Annual Meeting Abstract June 2021

Prediction of ranibizumab injection frequency in patients with macular edema due to retinal vein occlusion during as-needed dosing period of BRAVO and CRUISE Phase 3 trials

Yun Li; Verena Steffen; Fethallah Benmansour; Michel Friesenhahn; Zdenka Haskova

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):127.

ARVO Annual Meeting Abstract June 2021

Multi-modal Geographic Atrophy Lesion Growth Rate Prediction using Deep Learning

Qi Yang; Neha Anegondi; Verena Steffen; Christina Rabe; Daniela Ferrara; Simon S. Gao

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):235.

ARVO Annual Meeting Abstract June 2021

Analysis of numerical feature extraction from automated geographic atrophy segmentation

Theodore Spaide; Jasmine Patil; Jiaxiang Jiang; Neha Anegondi; Michael Kawczynski; Verena Steffen; Simon S. Gao

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2124.

ARVO Annual Meeting Abstract June 2021

DR progression analyses and its association with race and diabetes type in real-world patients with diabetes in the US

Geeta Lalwani; Charles Clifton Wykoff; Jayla Briggs; 4. Chin-Yu Lin; Verena Steffen; Zdenka Haskova

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1096.

ARVO Imaging in the Eye Conference Abstract July 2020

Change in geographic atrophy lesion area: comparison between fully automatic segmentation and semi-automatic segmentation

Jasmine Patil; Neha Anegondi; Verena Steffen; Simon Gao

Invest. Ophthalmol. Vis. Sci.. 2020; 61(9):PB0062.

ARVO Annual Meeting Abstract June 2020

Clinical Trial Versus Real-World Outcomes With Anti-VEGF Therapy for Central Retinal Vein Occlusion

Robert B Bhisitkul; Steven Blotner; Verena Steffen; Zdenka Haskova

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1304.

ARVO Annual Meeting Abstract June 2020

Development of geographic atrophy assessed by multimodal imaging in intermediate age-related macular degeneration

Steffen Schmitz-Valckenberg; Martina Braun; Sarah Thiele; Simon S. Gao; Hao Chen; Verena Steffen; Jian Dai; Lee Honigberg; Daniela Ferrara; Frank G Holz; Marlene Sassmannshausen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2353.

ARVO Annual Meeting Abstract June 2020

Initial lesion growth rates and other baseline prognostic factors can improve the design of clinical trials in Geographic Atrophy (GA)

Michel Friesenhahn; Christina Rabe; Simon S. Gao; Verena Steffen; Phillip Lai; Daniela Ferrara; Christopher Brittain; Lee Honigberg

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2988.

ARVO Annual Meeting Abstract June 2020

Lampalizumab inhibits ocular alternative complement activity in patients with geographic atrophy secondary to age-related macular degeneration

Michael Chang; Verena Steffen; Lee Honigberg; Rose Edmonds

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2992.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Deep Learning Approaches to Predict Geographic Atrophy Progression Using Three-Dimensional OCT Imaging

Topographic Clinical Insights From Deep Learning–Based Geographic Atrophy Progression Prediction

Artificial Intelligence Quantified Outer Retinal Disruption On Optical Coherence Tomography As Clinical Endpoints For Geographic Atrophy

Geographic Atrophy Segmentation Using Multimodal Deep Learning

HONU: A multicenter, prospective, observational study of the progression of intermediate age-related macular degeneration

Visual function loss in geographic atrophy: learnings from lampalizumab trial data

A hierarchical optical coherence tomography annotation workflow with crowds and medical experts

Development and validation of prognostic models to increase power of clinical trials for geographic atrophy (GA)

Quantification of lesion progression of incomplete and complete retinal pigment epithelium and outer retinal atrophy in age-related macular degeneration

Feature discovery using ablation studies for deep learning–based geographic atrophy (GA) progression prediction

Clinical trial versus real-world outcomes with anti-VEGF therapy for branch and central retinal vein occlusion

Prediction of ranibizumab injection frequency in patients with macular edema due to retinal vein occlusion during as-needed dosing period of BRAVO and CRUISE Phase 3 trials

Multi-modal Geographic Atrophy Lesion Growth Rate Prediction using Deep Learning

Analysis of numerical feature extraction from automated geographic atrophy segmentation

DR progression analyses and its association with race and diabetes type in real-world patients with diabetes in the US

Change in geographic atrophy lesion area: comparison between fully automatic segmentation and semi-automatic segmentation

Clinical Trial Versus Real-World Outcomes With Anti-VEGF Therapy for Central Retinal Vein Occlusion

Development of geographic atrophy assessed by multimodal imaging in intermediate age-related macular degeneration

Initial lesion growth rates and other baseline prognostic factors can improve the design of clinical trials in Geographic Atrophy (GA)

Lampalizumab inhibits ocular alternative complement activity in patients with geographic atrophy secondary to age-related macular degeneration

To View More...

You must be signed into an individual account to use this feature.